Study guide

9.5 Annual Screening and Treatment of Pre-Ulcerative Signs

NAWCCB Diabetic Wound Certified DWC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Foot Anatomy and Wound-Healing Physiology

1.1 Structural Anatomy of Plantar and Dorsal Skin, Subcutaneous Tissue, and Plantar Fat Pads 1.2 Osseous, Ligamentous, and Vascular Anatomy of the Foot 1.3 Cellular Phases of Wound Healing and Diabetic Pathophysiologic Impairments 1.4 Nail Unit and Periungual Anatomy Relevant to Diabetic Foot Care 1.5 Functional Neurovascular and Tendon Anatomy of the Foot

2 Chapter 2: Etiology and Pathogenesis of Diabetic Foot Ulcers

2.1 Pathogenesis and Clinical Manifestations of Diabetic Neuropathies 2.2 Peripheral Artery Disease and Microvascular Dysfunction in Diabetes 2.3 The Ulcer Triad: Repetitive Mechanical Stress, Deformity, and Unperceived Trauma

3 Chapter 3: Diagnostic Assessment: Sensory and Biomechanical Testing

3.1 Sensory Assessment and Loss of Protective Sensation (LOPS) 3.2 Biomechanical Assessment, Structural Foot Deformities, and Plantar Pressure Analysis 3.3 Diagnosis and Differential of Acute and Chronic Charcot Neuroarthropathy 3.4 Performance and Interpretation of TBI, Toe PPG, TcPO₂, and Skin Temperature Testing 3.5 Procedural Skills: Nail Trimming and Conservative Sharp Debridement 3.6 Procedural Skills: Total Contact Casting and Residual-Limb Wrapping

4 Chapter 4: Diagnostic Assessment: Vascular, Laboratory, and Imaging Studies

4.1 Bedside Noninvasive Vascular Diagnostics 4.2 Laboratory Evaluation: Inflammatory Markers, Glycemic Control, Nutritional Indices, and Renal Function 4.3 Microbiologic Diagnostics: Deep Tissue Curettage vs. Superficial Swabs, Bone Biopsy, and Culture Interpretation 4.4 Imaging of the Diabetic Foot: Plain Radiographs, Probe-to-Bone Test, MRI, and Nuclear Scintigraphy for Osteomyelitis

5 Chapter 5: Comprehensive Examination and Ulcer Classification

5.1 Patient History, Dermatologic Inspection, and Nail Pathology 5.2 Ulcer Assessment: Measurements, Tissue Characteristics, Exudate, Edges, Undermining, and Tunneling 5.3 Diabetic Foot Ulcer Classification Systems: Wagner Scale and University of Texas System 5.4 PEDIS, IWGDF/IDSA Staging, and SINBAD Classification Systems in Clinical Practice 5.5 Structured Medical, Foot, Medication, Family, and Psychosocial History 5.6 Dermatologic Examination: Diabetic Dermatoses and Nail Disorders 5.7 Structural Foot, Gait, Footwear, Insole, and Sock Examination

6 Chapter 6: Wound Bed Preparation, Debridement, and Advanced Dressings

6.1 Wound Bed Preparation (TIME Principle) and Debridement Modalities 6.2 Exudate Management and Topical Dressings in Diabetic Wound Care 6.3 Advanced Wound Modalities: Negative Pressure Wound Therapy and Cellular/Tissue-Based Products 6.4 Hyperbaric Oxygen Therapy, Biophysical Modalities, and Revascularization Indications 6.5 Treatment of Xerosis, Fissures, Nail Disorders, and Callus 6.6 Individualized Nutrition and Pain Management in Diabetic Foot Care 6.7 The Unsalvageable Foot: Amputation Decisions, Perioperative Care, and Rehabilitation

7 Chapter 7: Offloading Strategies and Biomechanical Interventions

7.1 Offloading Biomechanics and the Gold Standard: Total Contact Casting and Non-Removable Knee-High Devices 7.2 Removable Cast Walkers, Orthotic Walkers, Half-Shoes, and Wedge Offloading 7.3 Surgical Interventions for Pressure Relief: Tendon Lengthening, Metatarsal Head Resection, and Tenotomies

8 Chapter 8: Infection Management and Antimicrobial Stewardship

8.1 Clinical Diagnosis and Severity Grading of Diabetic Foot Infections 8.2 Empiric and Targeted Antimicrobial Therapy, Route Selection, and Antimicrobial Stewardship 8.3 Medical and Surgical Management of Diabetic Foot Osteomyelitis

9 Chapter 9: Prevention Strategies, Patient Education, and Multidisciplinary Care

9.1 IWGDF Risk Stratification Categories and Surveillance Intervals 9.2 Patient and Caregiver Education: Daily Inspection, Hygiene, Temperature Monitoring, and Avoidance of Self-Care Hazards 9.3 Prescription Therapeutic Footwear, Custom Insoles, Depth Shoes, and Rocker Soles 9.4 The Multidisciplinary Diabetic Foot Team: Core Specialties, Communication, and Urgent Referral Triggers 9.5 Annual Screening and Treatment of Pre-Ulcerative Signs 9.6 Metabolic Risk Reduction, Nutrition, Glucose Management, and Safe Activity 9.7 Inclusive Education, Ethical Care, Legal Duties, and Apparent Nonadherence

9.5 Annual Screening and Treatment of Pre-Ulcerative Signs

Key Takeaways Explain This Topic AI

Every person with diabetes receives at least annual comprehensive foot evaluation, with shorter intervals after risk classification.

The screen includes history, skin and nails, deformity, footwear, pulses or vascular clues, and 10-g monofilament testing plus another neurologic test.

A pre-ulcerative sign—hemorrhage in callus, blister, fissure, corn, pressure erythema, ingrown nail, or fungal lesion—is treated promptly along with its mechanical cause.

Moderate- and high-risk patients need integrated professional foot care, therapeutic footwear when indicated, education, and repeated surveillance.

Screening succeeds only when abnormal findings trigger a documented action, responsible clinician, interval, and escalation pathway.

Last updated: September 2026

Who Is Screened and How Often

Every person with diabetes should receive a comprehensive foot evaluation at least annually. The interval shortens when loss of protective sensation (LOPS), PAD, deformity, end-stage kidney disease, prior ulcer, or amputation raises risk. Under the IWGDF system, risk 0 is screened annually; risk 1 generally every 6 to 12 months; risk 2 every 3 to 6 months; and risk 3 every 1 to 3 months. These are integrated-care intervals, not a promise that a patient will remain safe until the next appointment.

The screen starts with history: previous ulcer or amputation, Charcot disease, vascular intervention, smoking, kidney disease, neuropathic symptoms, current foot problem, ability to inspect and care for the feet, and actual footwear use. Ask about walking barefoot, burns, falls, activity change, and any new red area, blister, callus, fissure, drainage, or nail problem.

Examination Components

Inspect dorsal, plantar, heel, interdigital, and nail surfaces. Look for dryness, maceration, fissure, callus, subcallous hemorrhage, blister, corn, deformity, edema, pressure erythema, ulcer, fungal disease, and nail-fold inflammation. Examine foot shape and joint mobility, especially prominent metatarsal heads, hallux limitation, claw or hammer toes, prior amputation, and Charcot change. Evaluate the shoes and insoles for fit, depth, seams, foreign bodies, wear, compression, and whether they are used indoors as well as outdoors.

Palpate pedal pulses and assess vascular symptoms and skin clues. An abnormal history, absent pulse, ulcer, gangrene, or nonhealing lesion calls for objective perfusion evaluation; palpation alone cannot exclude PAD. Neurologic screening includes a 10-g monofilament plus at least one other test , such as vibration with a 128-Hz tuning fork, pinprick, temperature sensation, or ankle reflex. Follow the selected protocol and test enough sites to avoid labeling LOPS from one inattentive response. At a tested site, repeated correct and incorrect responses distinguish perception from guessing.

Treating Pre-Ulcerative Signs

Prevention is active care. A dark hemorrhage within callus may hide tissue injury. A trained professional reduces callus when safe, inspects the underlying skin, and offloads the site. A blister is protected from further friction; the roof is generally preserved when intact, with drainage decisions based on size, location, infection risk, and clinical technique. A fissure is protected and surrounding dry skin moisturized while heel stress and infection are addressed. Corns and pressure erythema trigger shoe and deformity correction.

Thick nails are reduced safely when they cause shoe or adjacent-toe pressure. An ingrown margin or paronychia is treated according to inflammation, abscess, infection extent, perfusion, and recurrence. Tinea pedis and onychomycosis are managed to reduce fissuring and nail pressure, with diagnostic confirmation when systemic nail therapy is considered. Patients with neuropathy or PAD should not use chemical corn removers, blades, or heating devices.

A pre-ulcerative sign is a time-sensitive warning , but not every finding requires an emergency department. Same-day or urgent escalation is appropriate for spreading infection, wet gangrene, new necrosis, severe ischemic symptoms, a hot swollen neuropathic foot suspicious for Charcot disease, deep tissue exposure, or systemic illness. Lesser findings still receive a defined appointment and action rather than “watch and wait” without protection.

Integrated Foot Care

For moderate or high risk, prevention combines trained foot care, appropriate footwear or orthoses, structured education, and regular review. A person with deformity or pre-ulcerative signs may need extra-depth or custom options. A person with a healed plantar ulcer should receive therapeutic footwear whose pressure-relieving effect has been demonstrated and should use it consistently. Footwear is reassessed because materials compress and feet change.

Education is practical: inspect all surfaces daily using a mirror or helper, wash and dry carefully, moisturize dry intact skin but not between toes, never walk barefoot, check shoes before wearing, and seek help promptly for a lesion. Teach-back and demonstration are more reliable than handing out a brochure.

Closing the Loop

Document risk category and the findings that support it. For each abnormality, record the intervention, who will perform it, the follow-up interval, and what triggers earlier contact. Communicate with primary care, podiatry, vascular, diabetes, rehabilitation, or footwear professionals as needed. Screening prevents ulcers only when detection leads to effective care and the patient can access and follow the plan.

Example of a Closed Prevention Loop

A new dorsal-toe red mark should generate more than “monitor.” Document the matching shoe contact, protect the skin, modify or replace the footwear, set a short review interval, and tell the patient which change requires same-day contact. At review, confirm that the mark resolved and that the new accommodation did not shift pressure elsewhere. This detection-action-verification loop is the practical purpose of surveillance.

Risk-Based Surveillance

  • IWGDF risk Core pattern Routine interval
  • 0 No LOPS and no PAD Annual
  • 1 LOPS or PAD alone Every 6–12 months
  • 2 LOPS with PAD or deformity, or PAD with deformity Every 3–6 months
  • 3 LOPS or PAD plus prior ulcer/amputation or end-stage kidney disease Every 1–3 months

A new lesion overrides the routine interval and is evaluated sooner.